Search Full Text
Now showing items 1-1 of 1
The Radiosensitizing Potential of Rigosertib and Dinaciclib in Ewing's Sarcoma Cells
(Georgetown University, 2015)
Ewing’s sarcoma is the second most frequent bone cancer. However, it is still a relatively uncommon cancer, with only approximately 225 new cases diagnosed in patients under 20 years old each year in North America. Despite ...